Target intelligence / Profile preview

Prolyl oligopeptidase (POP) (POP)

Target
POP
Molecular classification
Enzyme, Serine protease, S9 family peptidase
01

Overview

Prolyl oligopeptidase (POP), also known as prolyl endopeptidase (PREP), is a large cytosolic serine protease that specifically cleaves peptide bonds on the carboxyl side of proline residues in peptides shorter than 30 amino acids [1]. It is highly expressed in the brain and is involved in the maturation and degradation of neuropeptides such as substance P, neurotensin, and vasopressin [2]. Beyond its catalytic role, POP has been identified as a key modulator of alpha-synuclein aggregation and autophagy, making it a significant therapeutic target for Parkinson's disease and other neurodegenerative disorders [3]. While traditional drug discovery has focused on the enzyme's active site, recent research has highlighted an alternative allosteric site located within the β-propeller domain [4]. Targeting this allosteric site offers a novel mechanism to regulate POP's protein-protein interactions and enzymatic activity with potentially improved selectivity and reduced off-target effects compared to active-site inhibitors [2]. This approach is currently being explored to develop treatments for cognitive deficits and synucleinopathies [4]. The β-propeller domain acts as a gatekeeper for the active site, and allosteric ligands can influence the opening and closing of this domain [3]. Consequently, allosteric modulators of POP represent a promising class of compounds for precision medicine in neurology [4].

Other names
Prolyl endopeptidasePREPPost-proline cleaving enzymePE
02

Mechanism of action

Allosteric modulation of enzyme activity and protein-protein interactions, specifically targeting the β-propeller domain to inhibit alpha-synuclein aggregation and regulate neuropeptide processing.

03

Biological functions

Neuropeptide metabolismRegulation of alpha-synuclein aggregationModulation of autophagyProtein-protein interaction
04

Disease associations

Parkinson's diseaseAlzheimer's diseaseSchizophreniaCognitive impairment
05

Safety considerations

Potential off-target effects on related prolyl peptidases like DPP4Possible disruption of neuropeptide homeostasis
06

Interacting drugs

KYP-2047

4 more in the full profile.

07

Biomarkers

PREP activity in cerebrospinal fluidPREP protein levels in brain tissue

Beyond the preview

Go deeper on Prolyl oligopeptidase (POP) (POP).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prolyl oligopeptidase (POP) (POP).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call